Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study.BACKGROUND/AIM
 The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy.


 Our cohort comprised 14 CML patients who were treated with imatinib between July 2010 and September 2018.  Two patients underwent haematopoietic stem cell transplantation due to unsatisfactory response to imatinib.


 Imatinib is effective in treating paediatric CML and limits the progression to advanced stages, however, the quality of life still needs to be optimised.
imatinib
Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study.BACKGROUND/AIM
 The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy.


 Our cohort comprised 14 CML patients who were treated with imatinib between July 2010 and September 2018.  Two patients underwent haematopoietic stem cell transplantation due to unsatisfactory response to imatinib.


 Imatinib is effective in treating paediatric CML and limits the progression to advanced stages, however, the quality of life still needs to be optimised.
imatinib
Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study.BACKGROUND/AIM
 The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy.


 Our cohort comprised 14 CML patients who were treated with imatinib between July 2010 and September 2018.  Two patients underwent haematopoietic stem cell transplantation due to unsatisfactory response to imatinib.


 Imatinib is effective in treating paediatric CML and limits the progression to advanced stages, however, the quality of life still needs to be optimised.
imatinib
Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study.BACKGROUND/AIM
 The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy.


 Our cohort comprised 14 CML patients who were treated with imatinib between July 2010 and September 2018.  Two patients underwent haematopoietic stem cell transplantation due to unsatisfactory response to imatinib.


 Imatinib is effective in treating paediatric CML and limits the progression to advanced stages, however, the quality of life still needs to be optimised.
imatinib
Efficacy and Safety of Imatinib in Paediatric CML - A Single Centre Study.BACKGROUND/AIM
 The dire clinical course of paediatric CML is further exacerbated by the adverse effects of long-term imatinib therapy.


 Our cohort comprised 14 CML patients who were treated with imatinib between July 2010 and September 2018.  Two patients underwent haematopoietic stem cell transplantation due to unsatisfactory response to imatinib.


 Imatinib is effective in treating paediatric CML and limits the progression to advanced stages, however, the quality of life still needs to be optimised.
imatinib